Patent: RE47415
✉ Email this page to a colleague
Summary for Patent: RE47415
Title: | Pyrimidinecarboxamides as CXCR2 modulators |
Abstract: | There is disclosed pyridine- and pyrimidinecarboxamide compounds useful as pharmaceutical agents, synthesis processes, and pharmaceutical compositions which include pyridine- and pyrimidinecarboxamides compounds. More specifically, there is disclosed a genus of CXCR2 inhibitor compounds that are useful for treating a variety of inflammatory and neoplastic disorders. |
Inventor(s): | Maeda; Dean Y. (Seattle, WA), Zebala; John A. (Issaquah, WA) |
Assignee: | Syntrix Biosystems, Inc. (Auburn, WA) |
Application Number: | 15/461,278 |
Patent Claims: | see list of patent claims |
Details for Patent RE47415
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Jubilant Hollisterstier Llc | N/A | positive skin test control-histamine | Injection | 103891 | 03/13/1924 | ⤷ Try a Trial | 2029-02-17 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |